Whether it is TIDM or TIIDM, if patients do not treat their hyperglycemia through appropriate medical interventions, they may face a series of severe consequences like blindness, kidney failure, or amputation
OrderlyMeds does not accept insurance for any treatments, including branded Wegovy or Zepbound
Areas of Research Interest Published research exploring RETA commonly investigates: Integrated metabolic signalling across multiple hormone pathways Crosstalk between GLP-1, GIP, and glucagon receptor systems Energy utilisation and nutrient-responsive signalling mechanisms Hormonal regulation processes in experimental metabolic models These research areas are explored exclusively in laboratory and pre-clinical research settings
Novo Nordisk collected $26 billion from semaglutide products (Ozempic, Wegovy) in 2024
Eli Lilly is making a preemption argument, saying that the FDA approved warning labels for Trulicity and its other GLP-1 drugs, so the company cannot be held legally liable